CD33 and Clusterin Interact Biophysically and Genetically to Modulate Alzheimer Risk
Dodd, R. B.; Enomoto, M.; Zhou, Y.; Sato, K.; Zhang, Y.; Chen, F.; Acheson, B.; Ghaffari, D.; Sayn-Wittgenstein, E.; Manning, J. J.; Dukas, G. V.; Patel, R.; Schweizer Burguete, A.; Kralovec, M. J.; Rashid, M.; Hall, J. L.; Tamucci, K. A.; Chatila, Z. K.; Liu, M.; Lee, A. J.; Vardarajan, B. N.; Taga, M.; Pollari, S.; Rabinovitch, A.; Rillahan, C. D.; Bobkov, A. A.; Sergienko, E.; Meadows, W.; Qamar, S. S.; Randle, S. J.; Johnson, C. M.; Sevalle, J.; Griffen, J.; Bohm, C.; Ikura, M.; Xian, X.; Herz, J.; Kelly, M. A.; West, J.; Satapathy, S.; Wilson, M. R.; Javitch, J. A.; Fraser, P.; Bennett, D
Show abstract
We report the results of structural, functional and genetic studies on the CD33 sialic acid- binding receptor that reveal how non-coding variants in CD33 alter risk for Alzheimers disease (AD). The full-length CD33M isoform, whose expression is upregulated by non-coding AD-risk alleles, preferentially forms dimers at the cell surface, where they interact with AD-related proteins (clusterin and A{beta}). This interaction induces CD33M inhibitory signalling and downregulates protective microglial functions including phagocytic removal of amyloid plaques. Human brain expression quantitative trait loci (eQTL) and causal mediation analyses confirm that quantitative interactions between CLU and CD33 genotypes modulate AD phenotypes and suggest that genotypes at these loci might be used to personalise future therapeutic approaches. Our work also highlights several other unexpected aspects of CD33 biology, including a soluble shed extracellular fragment of CD33M and a similar soluble secreted product arising from a truncating mutation in the CD33 extracellular domain (CD33M{Delta}4bp).
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Wild-type sTREM2 blocks Aβ aggregation and neurotoxicity, while the Alzheimer's R47H mutant does the opposite 96%
- PFN2 and NAA80 cooperate to efficiently acetylate the N-terminus of actin 95%
- JNK activity modulates postsynaptic scaffold protein SAP102 and kainate receptor dynamics in dendritic spines 94%
Similar papers in this journal
- GFAT2 and AMDHD2 act in tandem to control the hexosamine biosynthetic pathway 95%
- Identification of a conserved neutralizing epitope present on spike proteins from all highly pathogenic coronaviruses 95%
- S-acylation targets ORAI1 channels to lipid rafts for efficient Ca2+ signaling by T cell receptors at the immune synapse 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.